2019 专家共识声明:多发性骨髓瘤首次复发的正确评估

2019-05-10 国外血液科相关专家小组 Curr Hematol Malig Rep. 2019 May 10.

多发性骨髓瘤(MM)是一种克隆性浆细胞异常增殖的恶性疾病,是血液系统第2位常见恶性肿瘤,常见于老年人群。本文主要通过回顾MM复发时表现及分类的当前证据,为多发性骨髓瘤首次复发的正确评估和管理提供指导建议。

中文标题:

2019 专家共识声明:多发性骨髓瘤首次复发的正确评估

英文标题:

Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma.

发布日期:

2019-05-10

简要介绍:

多发性骨髓瘤(MM)是一种克隆性浆细胞异常增殖的恶性疾病,是血液系统第2位常见恶性肿瘤,常见于老年人群。本文主要通过回顾MM复发时表现及分类的当前证据,为多发性骨髓瘤首次复发的正确评估和管理提供指导建议。 

拓展指南:多发性骨髓瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 专家共识声明:多发性骨髓瘤首次复发的正确评估)] GetToolGuiderByIdResponse(projectId=1, id=7e8631c001ea430e, title=2019 专家共识声明:多发性骨髓瘤首次复发的正确评估, enTitle=Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma., guiderFrom=Curr Hematol Malig Rep. 2019 May 10., authorId=null, author=, summary=多发性骨髓瘤(MM)是一种克隆性浆细胞异常增殖的恶性疾病,是血液系统第2位常见恶性肿瘤,常见于老年人群。本文主要通过回顾MM复发时表现及分类的当前证据,为多发性骨髓瘤首次复发的正确评估和管理提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=971, associationName=国外血液科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Fri May 10 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>多发性骨髓瘤(MM)是一种克隆性浆细胞异常增殖的恶性疾病,是血液系统第2位常见恶性肿瘤,常见于老年人群。本文主要通过回顾MM复发时表现及分类的当前证据,为多发性骨髓瘤首次复发的正确评估和管理提供指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>多发性骨髓瘤</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=01adf1c001e306b2" title="多发性骨髓瘤遗传学检测专家共识" target=_blank>多发性骨髓瘤遗传学检测专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a6ad81c001e29207" title="2018 JSH实践指南:血液恶性肿瘤—骨髓瘤:多发性骨髓瘤相关疾病" target=_blank>2018 JSH实践指南:血液恶性肿瘤—骨髓瘤:多发性骨髓瘤相关疾病</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=1bcb51c001e12340" title="2019 IMWG共识声明:多发性骨髓瘤椎体压缩骨折经皮椎体成形术和球囊后凸成形术骨水泥填充的作用" target=_blank>2019 IMWG共识声明:多发性骨髓瘤椎体压缩骨折经皮椎体成形术和球囊后凸成形术骨水泥填充的作用</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=4f9311c00169a388" title="多发性骨髓瘤患者感染并发症的管理:共识的建议" target=_blank>多发性骨髓瘤患者感染并发症的管理:共识的建议</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=05e211c001666ac8" title="NCCN临床实践指南:多发性骨髓瘤(2019.V2)" target=_blank>NCCN临床实践指南:多发性骨髓瘤(2019.V2)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%A4%9A%E5%8F%91%E6%80%A7%E9%AA%A8%E9%AB%93%E7%98%A4" target=_blank>有关多发性骨髓瘤更多指南</a></ul>, tagList=[TagDto(tagId=321, tagName=多发性骨髓瘤), TagDto(tagId=3230, tagName=复发)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=16474, appHits=300, showAppHits=9, pcHits=14694, showPcHits=2499, likes=71, shares=5, comments=2, approvalStatus=1, publishedTime=Sun Jun 02 16:33:30 CST 2019, publishedTimeString=2019-05-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 02 16:33:30 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:36:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 专家共识声明:多发性骨髓瘤首次复发的正确评估)])
2019 专家共识声明:多发性骨髓瘤首次复发的正确评估
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2131054, encodeId=90072131054c8, content=早期复发是几个月?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Ew1TicATFhibUBIZLSHdpI5rBWeOKhJsaicsmvo6nDkUa02TnSaZ9SqhgKm9ibGF4LHrQCuficjdnO2NolqG3xGQblA/132, createdBy=f9fa2395757, createdName=gangan2008, createdTime=Mon May 08 23:47:38 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=367374, encodeId=c04336e3746f, content=谢谢分享谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Thu Jun 06 16:09:15 CST 2019, time=2019-06-06, status=1, ipAttribution=)]
    2023-05-08 gangan2008 来自四川省

    早期复发是几个月?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2131054, encodeId=90072131054c8, content=早期复发是几个月?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Ew1TicATFhibUBIZLSHdpI5rBWeOKhJsaicsmvo6nDkUa02TnSaZ9SqhgKm9ibGF4LHrQCuficjdnO2NolqG3xGQblA/132, createdBy=f9fa2395757, createdName=gangan2008, createdTime=Mon May 08 23:47:38 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=367374, encodeId=c04336e3746f, content=谢谢分享谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Thu Jun 06 16:09:15 CST 2019, time=2019-06-06, status=1, ipAttribution=)]
    2019-06-06 1e0ece0dm09(暂无匿称)

    谢谢分享谢谢分享

    0